AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
AXIM Biotechnologies's operating cash flow for the twelve months ending Jun 30, 2024 was -$759.00K. For fiscal 2023 it was -$1.03M. The highest annual figure on record is $21.11K in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$1.03M | – |
| FY2022 | Dec 31, 2022 | -$2.04M | – |
| FY2021 | Dec 31, 2021 | -$2.49M | – |
| FY2020 | Dec 31, 2020 | -$3.22M | – |
| FY2019 | Dec 31, 2019 | -$5.04M | – |
| FY2018 | Dec 31, 2018 | -$4.85M | – |
| FY2017 | Dec 31, 2017 | -$3.08M | – |
| FY2016 | Dec 31, 2016 | -$1.29M | – |
| FY2015 | Dec 31, 2015 | -$1.54M | – |
| FY2014 | Dec 31, 2014 | -$339.00K | – |
| FY2013 | Dec 31, 2013 | -$33.02K | -256.4% |
| FY2012 | Dec 31, 2012 | $21.11K | +422.7% |
| FY2011 | Dec 31, 2011 | $4.04K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -$261.54K | – |
| Q1 FY2024 | Mar 31, 2024 | -$252.51K | – |
| Q4 FY2023 | Dec 31, 2023 | $19.56K | – |
| Q3 FY2023 | Sep 30, 2023 | -$264.50K | – |
| Q2 FY2023 | Jun 30, 2023 | -$643.59K | – |
| Q1 FY2023 | Mar 31, 2023 | -$141.96K | – |
| Q4 FY2022 | Dec 31, 2022 | -$315.51K | – |
| Q3 FY2022 | Sep 30, 2022 | -$321.23K | – |
| Q2 FY2022 | Jun 30, 2022 | -$703.88K | – |
| Q1 FY2022 | Mar 31, 2022 | -$703.72K | – |
| Q4 FY2021 | Dec 31, 2021 | -$792.93K | – |
| Q3 FY2021 | Sep 30, 2021 | -$532.84K | – |
| Q2 FY2021 | Jun 30, 2021 | -$595.53K | – |
| Q1 FY2021 | Mar 31, 2021 | -$565.46K | – |
| Q4 FY2020 | Dec 31, 2020 | -$614.92K | – |
| Q3 FY2020 | Sep 30, 2020 | -$790.17K | – |
| Q2 FY2020 | Jun 30, 2020 | -$737.10K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.07M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.41M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.75M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.15M | – |
| Q1 FY2019 | Mar 31, 2019 | -$728.55K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.04M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.05M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.59M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.16M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.02M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.02M | – |
| Q2 FY2017 | Jun 30, 2017 | -$468.61K | – |
| Q1 FY2017 | Mar 31, 2017 | -$580.92K | – |
| Q4 FY2016 | Dec 31, 2016 | -$532.45K | – |
| Q3 FY2016 | Sep 30, 2016 | -$216.14K | – |
| Q2 FY2016 | Jun 30, 2016 | -$352.36K | – |
| Q1 FY2016 | Mar 31, 2016 | -$193.20K | – |
| Q4 FY2015 | Dec 31, 2015 | -$418.80K | – |
| Q3 FY2015 | Sep 30, 2015 | -$490.80K | – |
| Q2 FY2015 | Jun 30, 2015 | -$163.70K | – |
| Q1 FY2015 | Mar 31, 2015 | -$465.87K | – |
| Q4 FY2014 | Dec 31, 2014 | -$288.68K | – |
| Q3 FY2014 | Sep 30, 2014 | -$50.03K | – |
See a number that looks wrong?